Novo Nordisk struggles in hemophilia competition with Roche

The Danish pharmaceutical company needs to move at a faster pace if it is to compete with Roche’s blockbuster Hemlibra for younger patients with hemophilia. But Novo Nordisk has one advantage.

发布者:BY IDA JORGENSEN,转转请注明出处:https://robotalks.cn/novo-nordisk-struggles-in-hemophilia-competition-with-roche/

(0)
上一篇 1天前
下一篇 1天前

相关推荐

发表回复

您的电子邮箱地址不会被公开。 必填项已用 * 标注

联系我们

400-800-8888

在线咨询: QQ交谈

邮件:admin@example.com

工作时间:周一至周五,9:30-18:30,节假日休息

关注微信
社群的价值在于通过分享与互动,让想法产生更多想法,创新激发更多创新。